Inter-clinician agreement on the recognition of clinical pigmentary characteristics of patients with cutaneous malignant melanoma. Studies of melanocytic nevi, VI.

por Roush, G. C., Barnhill, R. L., Ernstoff, M. S., Kirkwood, J. M.
Publicado em 1991

Inflammatory cell infiltrate in a responding metastatic nodule after vaccine-based immunotherapy

por LOGAN, T F, BANNER, B, RAO, U, ERNSTOFF, M S, WOLMARK, N, WHITESIDE, T L, MIKETIC, L, KIRKWOOD, J M
Publicado em 1998

Phase 3 study of docosahexaenoic acid–paclitaxel versus dacarbazine in patients with metastatic malignant melanoma

por Bedikian, A. Y., DeConti, R. C., Conry, R., Agarwala, S., Papadopoulos, N., Kim, K. B., Ernstoff, M.
Publicado no Ann Oncol (2011)

Recent Skin Self-Examination and Doctor Visits in Relation to Melanoma Risk and Tumor Depth

por Titus, L.J., Clough-Gorr, K., Mackenzie, T.A., Perry, A., Spencer, S.K., Weiss, J., Abrahams-Gessel, S., Ernstoff, M.S.
Publicado em 2012

Homozygous deletions within human chromosome band 9p21 in melanoma.

por Fountain, J W, Karayiorgou, M, Ernstoff, M S, Kirkwood, J M, Vlock, D R, Titus-Ernstoff, L, Bouchard, B, Vijayasaradhi, S, Houghton, A N, Lahti, J
Publicado em 1992

Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group

por Puzanov, I., Diab, A., Abdallah, K., Bingham, C. O., Brogdon, C., Dadu, R., Hamad, L., Kim, S., Lacouture, M. E., LeBoeuf, N. R., Lenihan, D., Onofrei, C., Shannon, V., Sharma, R., Silk, A. W., Skondra, D., Suarez-Almazor, M. E., Wang, Y., Wiley, K., Kaufman, H. L., Ernstoff, M. S.
Publicado no J Immunother Cancer (2017)